Hey mate,
I can understand the IHL-42X landscape can be a little confusing with two pending trials
IHL-42x will be studied in two separate trials done in parallel.
>> BA/BE study in South Australia at the C-MAX facility has received HREC approval today to commence.
>> Phase 2/3 Trial in Europe & USA with up to 400 participants over 45 trial locations
https://stocknessmonster.com/announcements/ihl.asx-3A620063/ (Latest trial update)
Each trial is independent of the other, so HREC approval today for the BA/BE study.
If the HREC approval was not granted/declined it would have created some uncertainty, as the BA/BE study will be instrumental in the longer term.
As @kingkev said it's another box ticked on the journey.
The BOD is getting all their ducks aligned for IHL-42X,
we are expecting the IND filing for IHL-42x (phase 2/3 Trial - under FDA supervision) to eventuate in the coming days/weeks
and this BA/BE study will complement and support the eventual NDA application once the phase 2/3 Trial is completed.
Good luck @Hangover
- Forums
- ASX - By Stock
- IHL
- Ann: IHL Receives Ethics Approval BA/BE Clinical Trial.
Ann: IHL Receives Ethics Approval BA/BE Clinical Trial., page-7
-
- There are more pages in this discussion • 16 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IHL (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO
Charles Armstrong
CEO
Previous Video
Next Video
SPONSORED BY The Market Online